Return to search results.
Complete title: A Phase 1, Open-Label Study of the Safety and Pharmacokinetics of Escalating Doses of DSTP30862 in Patients with Metastatic Castration-Resistant Prostate Cancer
|Research Study Number||20121064|
|Principal Investigator||Tia Higano, MD|
Research Study Description
Eligibility Criteria (must meet the following to participate in this study)
Other eligibility criteria may apply.
Prostate Cancer; Solid Tumors
Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.